CSS
FLGT icon

Cubist Systematic Strategies’s Fulgent Genetics FLGT Stock Holding History

Cubist Systematic Strategies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.77M Sell
122,750
-34,176
-22% -$704K 0.01% 1349
2025
Q2 		$3.12M Sell
156,926
-64,295
-29% -$1.25M 0.01% 1308
2025
Q1 		$3.74M Buy
221,221
+165,828
+299% +$2.82M 0.02% 1057
2024
Q4 		$1.02M Buy
55,393
+22,833
+70% +$446K 0.01% 1776
2024
Q3 		$708K Buy
+32,560
New +$728K ﹤0.01% 2031
2024
Q2 		– Sell
-50,940
Closed -$1.11M – 3314
2024
Q1 		$1.11M Buy
50,940
+47,563
+1,408% +$1.18M 0.01% 2084
2023
Q4 		$97.6K Sell
3,377
-43,724
-93% -$1.17M ﹤0.01% 3184
2023
Q3 		$1.26M Buy
47,101
+12,863
+38% +$439K 0.01% 1711
2023
Q2 		$1.27M Buy
34,238
+9,586
+39% +$334K 0.01% 1806
2023
Q1 		$770K Buy
24,652
+1,367
+6% +$44K ﹤0.01% 2389
2022
Q4 		$693K Buy
23,285
+18,412
+378% +$659K ﹤0.01% 2771
2022
Q3 		$186K Sell
4,873
-12,273
-72% -$615K ﹤0.01% 3805
2022
Q2 		$935K Sell
17,146
-10,959
-39% -$602K 0.01% 2536
2022
Q1 		$1.75M Buy
28,105
+23,326
+488% +$1.54M 0.01% 1592
2021
Q4 		$481K Buy
4,779
+2,894
+154% +$254K ﹤0.01% 2477
2021
Q3 		$170K Sell
1,885
-20,263
-91% -$1.84M ﹤0.01% 2630
2021
Q2 		$2.04M Buy
22,148
+18,431
+496% +$1.47M 0.02% 1064
2021
Q1 		$359K Buy
+3,717
New +$384K ﹤0.01% 2155
2020
Q4 		– Sell
-10,299
Closed -$412K – 2596
2020
Q3 		$412K Buy
+10,299
New +$322K 0.01% 1855
2020
Q1 		– Sell
-36,429
Closed -$470K – 2244
2019
Q4 		$470K Buy
+36,429
New +$433K 0.01% 1585

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cubist Systematic Strategies's FLGT Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Fulgent Genetics (FLGT) stake by 22% in Q3 2025, selling an estimated $704K and leaving 122,750 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #1349.

Cubist Systematic Strategies first reported a position in FLGT in Q4 2019 and has held it in 20 quarters since. The position peaked at $3.74M in Q1 2025. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Cubist Systematic Strategies held 122,750 shares of Fulgent Genetics worth $2.77M as of Q3 2025.
  • Cubist Systematic Strategies sold 34,176 Fulgent Genetics shares in Q3 2025, an estimated $704K.
  • Fulgent Genetics made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1349 holding.
  • Cubist Systematic Strategies first reported a position in Fulgent Genetics in Q4 2019 and has held it in 20 quarters since.
  • Cubist Systematic Strategies's Fulgent Genetics position peaked at $3.74M in Q1 2025.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.